chronic fatigue syndrome: a medical condition characterized by long-term fatigue and other symptoms that limit a person's ability to carry out ordinary daily activities.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
295 |
4. Check minimum number of eventsNone |
295 |
5. Include endpointsNone |
295 |
6. Filter based on genotype QC (FinnGen only) |
295 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G93
- Name in latin
- Syndroma lassitudinis postvirale
Similar endpoints
↥List of similar endpoints to
Postviral fatigue syndrome
based on the number of shared cases.
Similar with more cases:
- Cerebral cysts
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1622 | 1089 | 525 |
| Only index persons | 1588 | 1074 | 514 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.01 |
| Only index persons | 0.03 | 0.04 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 34.76 | 35.80 | 32.61 |
| Only index persons | 34.81 | 35.74 | 32.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 295 | 236 | 59 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.03 |
| Median age at first event (years) | 38.57 | 38.56 | 38.60 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 254
- Matched controls
- 2538
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G93.3
ICD-10 Finland
Postviral fatigue syndrome
+∞
323.0
254
*
R53
ICD-10 Finland
Malaise and fatigue
14.8
78.6
165
282
F48.0
ICD-10 Finland
Neurasthenia
121.5
30.4
32
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
9.3
29.8
66
92
N06AX16
ATC
venlafaxine; oral
5.5
27.4
95
247
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
12.9
25.9
47
44
TAB00
NOMESCO Finland
Lumbar puncture
14.1
25.4
44
37
Z01.8
ICD-10 Finland
Other specified special examinations
4.8
24.7
100
302
R68.88
ICD-10 Finland
Other specified general symptoms and signs, not elsewhere classified.
60.1
23.6
27
5
N06AX21
ATC
duloxetine; oral
6.4
23.5
68
138
M79.7
ICD-10 Finland
Fibromyalgia
12.1
23.2
43
42
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
9.0
23.1
51
69
N04BC09
ATC
rotigotine; transdermal
251.8
23.0
23
*
N04BC05
ATC
pramipexole; oral
10.9
23.0
45
49
N03AX12
ATC
gabapentin; oral
5.7
22.5
72
165
R50.9
ICD-10 Finland
Fever, unspecified
5.5
22.4
75
181
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.6
20.9
83
240
A04
ICPC
Weakness/tiredness general
5.1
20.8
74
190
XA800
NOMESCO Finland
Neuropsychological investigation
10.4
20.6
41
46
R51.80
ICD-10 Finland
Headache
4.3
20.3
88
276
L28
ICPC
Limited function/disability (L)
6.4
20.1
56
107
M35.7
ICD-10 Finland
Hypermobility syndrome
15.0
19.9
33
25
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
14.4
19.5
33
26
N06AX12
ATC
bupropion; oral
5.6
19.5
62
139
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
41.9
18.9
23
6
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.4
18.6
35
35
N03AX16
ATC
pregabalin; oral
4.1
18.2
83
269
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.5
17.3
47
86
A02BA02
ATC
ranitidine; systemic
4.5
16.3
63
172
H03AA01
ATC
levothyroxine sodium; systemic
3.6
16.2
89
333
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.5
15.7
89
338
H02AB06
ATC
prednisolone; systemic
2.9
15.1
141
755
G47.3
ICD-10 Finland
Sleep apnoea
4.0
15.1
67
208
R06.0
ICD-10 Finland
Dyspnoea
3.7
14.8
74
254
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
6.7
14.3
37
63
A02BC05
ATC
esomeprazole; systemic
2.9
14.0
121
610
N06BA07
ATC
modafinil; oral
79.5
13.7
15
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.4
13.7
42
89
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
19.6
13.6
20
11
M79.0
ICD-10 Finland
Rheumatism, unspecified
10.6
13.6
26
27
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
147.6
13.6
14
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.6
13.1
34
58
R42
ICD-10 Finland
Dizziness and giddiness
3.7
13.1
64
214
A28
ICPC
Limited function/disability NOS
6.9
12.8
32
52
N04BD01
ATC
selegiline; oral
73.6
12.7
14
*
R4110
NOMESCO Finland
Physiotherapy
3.1
12.6
84
349
N06AX11
ATC
mirtazapine; oral
2.8
12.6
105
508
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
12.4
127
693
C07AA05
ATC
propranolol; systemic
3.0
12.4
84
355
M79.1
ICD-10 Finland
Myalgia
3.6
12.4
61
204
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
8.3
12.3
27
36
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.8
12.3
103
496
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.6
12.1
31
52
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.4
11.9
45
119
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
7.4
11.8
28
42
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
31.7
11.8
15
5
N06AB04
ATC
citalopram; systemic
3.0
11.5
76
312
M54.2
ICD-10 Finland
Cervicalgia
4.9
11.4
38
88
Z2445
NOMESCO Finland
Psychologist
5.0
11.1
36
81
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
4.1
11.0
45
128
A02BC02
ATC
pantoprazole; systemic
2.5
11.0
160
1032
XF404
NOMESCO Finland
Ambulatory ECG
5.5
10.8
32
65
H02AB09
ATC
hydrocortisone; systemic
12.0
10.7
19
17
R03AC02
ATC
salbutamol; inhalant
2.5
10.7
164
1078
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
6.6
10.6
27
45
ZY010
NOMESCO Finland
Hospital outpatient
4.5
10.6
38
95
B03BA03
ATC
hydroxocobalamin; parenteral
8.8
10.6
22
27
N06AA09
ATC
amitriptyline; systemic
5.0
10.6
34
76
C07AB07
ATC
bisoprolol; oral
2.7
10.5
86
404
J45.9
ICD-10 Finland
Asthma, unspecified
3.3
10.3
56
200
K30
ICD-10 Finland
Functional dyspepsia
4.0
10.3
42
119
H04.10
ICD-10 Finland
Dry eye syndrome
4.5
10.3
37
93
UJF30
NOMESCO Finland
Ileoscopy through colon
4.2
10.1
39
105
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
10.1
96
490
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
17.6
10.0
15
9
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.6
9.7
46
148
N02AX02
ATC
tramadol; systemic, rectal
2.5
9.7
99
520
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.1
9.7
38
104
J31.0
ICD-10 Finland
Chronic rhinitis
4.0
9.6
39
110
R52.9
ICD-10 Finland
Pain, unspecified
4.3
9.5
35
90
N06BA04
ATC
methylphenidate; oral
6.2
9.5
25
44
G44.0
ICD-10 Finland
Cluster headache syndrome
22.7
9.4
13
6
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
+∞
9.4
9
*
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
5.6
9.4
27
53
G43.9
ICD-10 Finland
Migraine, unspecified
3.6
9.4
43
135
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.1
9.3
29
63
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
9.2
45
148
M03BX01
ATC
baclofen; systemic
12.1
9.2
16
14
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.2
9.2
35
93
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.4
9.2
46
155
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.9
9.1
61
249
N05BA04
ATC
oxazepam; oral
2.5
9.1
81
394
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.5
9.0
43
139
M25.5
ICD-10 Finland
Pain in joint
2.4
9.0
95
504
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.3
9.0
33
85
C01CA24
ATC
epinephrine; parenteral
3.7
8.9
39
118
A01
ICPC
Pain general/multiple sites
4.3
8.9
33
86
R5140
NOMESCO Finland
Monitoring the use of the aid
4.5
8.9
31
76
R4120
NOMESCO Finland
Occupational therapy
4.9
8.8
28
62
N05CF01
ATC
zopiclone; oral
2.6
8.7
76
362
J01AA02
ATC
doxycycline; systemic
2.4
8.7
193
1445
G44.8
ICD-10 Finland
Other specified headache syndromes
12.2
8.7
15
13
G50.1
ICD-10 Finland
Atypical facial pain
17.0
8.6
13
8
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.4
8.6
31
78
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.5
8.6
41
133
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.2
8.5
32
84
G43.3
ICD-10 Finland
Complicated migraine
6.2
8.5
22
38
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
11.3
8.4
15
14
Z01.9
ICD-10 Finland
Special examination, unspecified
5.8
8.4
23
43
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.1
8.4
22
39
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
4.1
8.3
32
86
Z2446
NOMESCO Finland
Social worker
3.7
8.3
36
108
L19
ICPC
Muscle symptom/complaint NOS
9.4
8.2
16
18
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
17.9
8.2
12
7
F32.1
ICD-10 Finland
Moderate depressive episode
3.7
8.1
35
104
N28
ICPC
Limited function/disability (N)
34.6
8.1
10
*
Z71.8
ICD-10 Finland
Other specified counselling
2.3
8.0
88
472
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
8.2
8.0
17
22
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
8.0
61
271
R52.2
ICD-10 Finland
Other chronic pain
7.4
7.9
18
26
R03AK11
ATC
formoterol and fluticasone; inhalant
11.3
7.9
14
13
N06AB10
ATC
escitalopram; oral
2.3
7.9
83
435
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
7.8
57
244
N03AX11
ATC
topiramate; oral
5.5
7.8
22
43
H02AA02
ATC
fludrocortisone; oral
25.9
7.6
10
*
N99
ICPC
Neurological disease other
25.9
7.6
10
*
J01FA09
ATC
clarithromycin; systemic
2.2
7.6
98
561
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.3
7.6
38
128
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.3
7.5
19
32
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.8
7.5
50
203
R03DC03
ATC
montelukast; oral
2.6
7.5
59
265
R68.81
ICD-10 Finland
A constant or recurrent sensitivity to experience symptoms and signs in relation to common factors in the environment, not elsewhere classified.
+∞
7.3
7
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.8
7.3
48
192
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
7.2
25
61
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.8
7.2
30
87
R00.2
ICD-10 Finland
Palpitations
3.6
7.2
32
98
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
3.2
7.2
38
133
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
20.7
7.2
10
5
N06AX26
ATC
vortioxetine; oral
3.4
7.2
34
110
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.4
7.2
34
110
SPAT1229
SPAT
Assessment of need for aid
5.2
7.2
21
43
XF402
NOMESCO Finland
ECG with work load test
4.1
7.1
27
72
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
7.1
118
749
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
7.1
60
279
G44.2
ICD-10 Finland
Tension-type headache
2.6
7.1
55
243
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.0
7.0
40
147
N05AH04
ATC
quetiapine; oral
2.4
7.0
67
333
U09.9
ICD-10 Finland
Post COVID-19 condition, unspecified
14.3
7.0
11
8
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
4.6
6.9
23
54
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
6.9
163
1188
M54.5
ICD-10 Finland
Low back pain
2.1
6.9
100
601
AA1AD
NOMESCO Finland
CT of head and brain
2.9
6.8
43
169
N03AE01
ATC
clonazepam; systemic
4.6
6.7
22
51
R03BA08
ATC
ciclesonide; inhalant
3.6
6.7
29
87
UJF92
NOMESCO Finland
Capsular endoscopy
8.2
6.7
14
18
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.4
6.7
23
56
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
12.7
6.6
11
9
N06AX17
ATC
milnacipran; oral
12.7
6.6
11
9
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.3
6.6
32
105
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.2
6.6
15
22
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
6.6
72
382
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.4
6.5
30
95
N17
ICPC
Vertigo/dizziness
3.1
6.5
36
129
Z3226
NOMESCO Finland
Physiotherapist
2.5
6.5
55
257
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
71.6
6.5
7
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
71.6
6.5
7
*
J01MA02
ATC
ciprofloxacin; systemic
2.1
6.4
86
493
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.7
6.4
44
182
R11
ICD-10 Finland
Nausea and vomiting
3.3
6.4
31
102
Z02.7
ICD-10 Finland
Issue of medical certificate
3.9
6.4
25
69
F34.1
ICD-10 Finland
Dysthymia
4.0
6.4
24
64
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.0
6.4
19
40
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
6.3
52
239
R51.81
ICD-10 Finland
Facial pain NOS
7.3
6.3
14
20
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.5
6.3
21
50
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.3
6.3
22
55
G90.8
ICD-10 Finland
Other disorders of autonomic nervous system
+∞
6.3
6
*
NXL00
NOMESCO Finland
Biopsy of muscle
27.4
6.3
8
*
U08.9
ICD-10 Finland
Personal history of COVID-19, unspecified
27.4
6.3
8
*
G43.8
ICD-10 Finland
Other migraine
6.0
6.3
16
28
R01AD09
ATC
mometasone; nasal
1.9
6.2
134
929
R39.1
ICD-10 Finland
Other difficulties with micturition
10.4
6.1
11
11
N29
ICPC
Neurological sympt/complt other
10.4
6.1
11
11
M03BC01
ATC
orphenadrine (citrate); systemic
2.1
6.1
77
430
N05CF02
ATC
zolpidem; oral
2.4
6.1
52
243
R20.2
ICD-10 Finland
Paraesthesia of skin
3.5
6.0
27
84
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036481) Cortisol [Moles/volume] in Serum or Plasma
161
216
15.21
127.12
2.4
1.8
nmol/l
376.7
368.9
0.20
150
203
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
141
190
13.30
109.20
2.9
2.1
au/ml
28.7
19.2
—
5
12
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
64
55
14.58
64.95
1.3
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
66
61
13.65
64.01
1.3
1.3
u/ml
264.1
165.0
2.20
46
37
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
66
63
13.21
62.66
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
149
390
6.70
59.19
1.7
1.4
titre
234.5
408.5
2.17
29
75
(3005719) IgG [Mass/volume] in Serum or Plasma
96
171
7.84
55.70
3.0
2.2
g/l
10.1
10.4
0.48
87
164
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
54
51
12.74
51.24
1.3
1.5
u/ml
83.7
110.0
1.51
24
13
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
66
83
9.96
51.17
1.8
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
189
683
5.92
50.44
2.1
1.7
pmol/l
97.1
95.3
0.20
106
385
(3048929) Epstein Barr virus Ab [Presence] in Serum
80
130
8.07
50.09
1.4
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
207
841
5.90
47.07
5.5
6.3
mmol/l
1.2
1.2
0.06
179
717
(3022948) Iron [Moles/volume] in Serum or Plasma
109
264
5.96
45.54
3.0
2.1
umol/l
16.5
14.5
2.04
101
243
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
97
211
6.36
45.48
2.7
2.2
%
29.1
25.1
2.04
88
183
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
189
739
5.33
44.25
4.9
6.2
mmol/l
1.2
1.2
0.16
178
684
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
210
931
5.36
40.97
3.1
2.3
nmol/l
75.6
71.8
1.19
202
871
(3035637) Corticotropin [Mass/volume] in Plasma
35
25
15.75
38.86
1.6
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
180
734
4.73
38.41
6.0
6.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
56
83
8.09
37.50
1.7
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
45
51
10.23
37.30
1.2
1.6
e6/l
1.0
2.2
1.40
35
40
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
45
51
10.23
37.30
1.3
1.6
e6/l
14.8
85.8
0.84
37
42
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
115
343
4.86
36.67
1.7
1.6
pmol/l
457.2
48718361.7
0.80
107
312
(4027681)
29
17
18.81
35.46
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
35
31
12.68
34.20
1.3
1.5
—
—
—
0
0
(4062490)
31
23
14.94
33.59
2.4
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
25
12
22.67
33.28
2.3
3.9
u/ml
356.6
374.8
0.09
25
12
(3001122) Ferritin [Mass/volume] in Serum or Plasma
241
1311
5.58
33.25
5.2
2.9
ug/l
80.8
67.6
0.92
235
1245
(3024561) Albumin [Mass/volume] in Serum or Plasma
173
742
4.22
33.09
3.5
4.5
g/l
38.0
37.4
0.73
162
694
(3012095) Magnesium [Moles/volume] in Serum or Plasma
94
260
4.84
32.50
3.2
3.6
mmol/l
0.8
0.8
0.36
84
247
(3013290) Carbon dioxide [Partial pressure] in Blood
33
30
12.26
31.66
1.5
1.9
kpa
5.0
5.1
0.16
33
30
(3012501) Base excess in Blood by calculation
33
30
12.26
31.66
1.5
1.9
mmol/l
1.3
3.5
3.04
18
24
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
158
662
3.99
30.67
3.1
2.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
133
495
4.07
30.67
3.3
3.5
ph
7.4
7.4
1.17
30
84
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
31
27
12.71
30.52
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
109
355
4.28
30.22
2.6
2.2
mosm/kgh2o
527.9
580.2
1.37
101
305
(3027315) Oxygen [Partial pressure] in Blood
32
30
11.84
30.06
1.5
1.9
kpa
9.9
9.8
0.12
32
30
(3006315) Basophils [#/volume] in Blood
222
1195
4.47
29.43
7.4
5.7
e9/l
0.0
0.0
0.20
208
1067
(3001604) Monocytes [#/volume] in Blood
221
1188
4.43
29.30
7.4
5.7
e9/l
0.5
0.5
0.21
207
1063
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
89
256
4.55
28.98
1.6
1.3
iu/ml
89.8
169.9
1.63
37
106
(3024980) IgG subclass 4 [Mass/volume] in Serum
34
37
10.26
28.83
2.0
1.6
g/l
0.5
0.5
0.02
26
28
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
23
13.35
28.51
2.0
1.2
g/l
0.4
0.4
0.18
21
17
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
23
13.35
28.51
2.0
1.2
g/l
6.0
6.4
0.19
21
17
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
23
13.35
28.51
2.0
1.2
g/l
3.0
2.9
0.08
21
16
(3006504) Eosinophils/100 leukocytes in Blood
211
1112
4.15
28.45
7.7
5.6
%
2.5
2.7
0.76
206
1047
(3013115) Eosinophils [#/volume] in Blood
225
1240
4.43
28.42
7.4
6.3
e9/l
0.2
0.2
0.48
215
1121
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
26
19
14.91
28.29
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
148
623
3.76
27.93
2.0
2.8
mmol/l
2.3
2.3
1.80
137
569
(3013707) Erythrocyte sedimentation rate by Westergren method
270
1722
7.70
27.85
6.3
3.6
mm/h
6.2
8.3
6.88
264
1611
(3019198) Lymphocytes [#/volume] in Blood
224
1244
4.33
27.65
7.4
5.7
e9/l
2.0
1.9
0.36
211
1130
(3013650) Neutrophils [#/volume] in Blood by Automated count
234
1353
4.53
26.94
8.2
8.7
e9/l
3.8
3.9
0.32
217
1192
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
29
28
11.38
26.65
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
138
577
3.61
25.90
3.1
2.6
e6/l
15.9
67.7
1.19
116
439
(3013826) Glucose [Moles/volume] in Serum or Plasma
206
1112
3.83
25.77
4.2
4.6
mmol/l
5.8
6.3
4.39
189
978
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
259
1640
5.75
25.72
7.4
6.3
u/l
70.4
73.5
0.55
251
1545
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
25
11.31
23.90
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
79
244
4.06
22.91
1.9
1.5
nmol/l
1116.5
1073.2
0.16
65
193
(3021960) Folate [Moles/volume] in Serum or Plasma
104
389
3.58
22.74
1.6
1.3
nmol/l
21.9
20.8
0.31
98
354
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
44
85
5.91
22.51
1.8
8.4
mmol/l
24.7
25.2
0.64
44
85
(3021589) Normoblasts [#/volume] in Blood
195
1074
3.41
22.39
9.7
7.4
e9/l
0.0
0.0
1.08
162
888
(3018095) Leukocytes [#/volume] in Urine
150
714
3.24
21.96
3.9
3.1
e6/l
13.2
65.6
1.18
118
470
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
22
20
11.81
20.90
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
119
512
3.22
20.40
3.1
2.5
e6/l
0.1
0.3
3.53
96
383
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
275
1958
6.97
20.37
6.7
4.2
pmol/l
14.4
14.3
0.61
270
1841
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
286
2268
9.55
20.03
8.0
4.7
mu/l
1.6
2.2
0.61
279
2160
(3047007) Chlamydophila sp Ab [Presence] in Serum
33
54
6.75
19.84
1.4
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
43
92
5.30
19.62
2.0
2.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
117
513
3.12
19.22
2.9
2.2
mg/l
2.2
2.8
3.33
101
446
(3023410) Appearance of Cerebral spinal fluid
24
28
9.24
19.16
1.7
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
193
1128
3.06
18.65
3.9
2.8
estimate
0.0
0.0
0.00
50
233
(3009445) Proteinase 3 Ab [Units/volume] in Serum
40
84
5.35
18.61
1.2
1.7
—
10.9
—
0
5
(3003327) Ova and parasites identified in Stool by Light microscopy
47
114
4.71
18.49
2.6
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
132
634
2.96
18.24
2.3
1.4
g/l
1.8
2.1
2.26
98
417
(3009261) Glucose [Presence] in Urine by Test strip
194
1146
3.02
18.21
3.9
2.9
estimate
0.0
0.0
0.00
54
232
(3021601) Nitrite [Presence] in Urine by Test strip
192
1132
2.99
18.01
5.0
4.0
estimate
0.0
0.0
0.50
53
236
(3037467) Urinalysis macro (dipstick) panel - Urine
239
1601
3.60
17.78
5.0
3.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
97
397
3.15
17.75
1.9
2.8
ug/g
38.5
84.5
4.26
69
311
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
277
3.41
17.41
2.5
2.4
e6/l
3.6
3.6
0.01
47
148
(40758558) Short blood count panel - Blood
120
564
2.90
17.03
5.1
6.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
19
19
10.62
16.87
1.5
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
114
525
2.91
16.75
3.2
2.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
24
34
7.60
16.35
1.6
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
93
389
3.03
16.20
2.6
2.3
e6/l
4.5
10.2
1.87
78
346
(40768797) Stomach Pathology biopsy report
74
271
3.31
16.16
1.3
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
27
45
6.50
15.88
1.2
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
149
814
2.68
15.43
3.3
3.1
u/l
24.4
28.5
1.56
143
782
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
27
47
6.22
15.22
1.2
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
31
7.59
15.03
1.6
1.3
nmol/l
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
173
1029
2.65
14.89
4.6
5.3
umol/l
9.2
9.9
0.80
161
976
(3044889) 12 lead EKG panel
211
1391
2.82
14.63
3.4
2.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
53
5.73
14.49
1.3
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
21
9.06
14.28
1.2
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
116
579
2.65
14.16
4.1
3.2
estimate
0.0
0.0
1.08
54
238
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
133
712
2.58
14.03
1.6
1.3
u/ml
2.6
1.9
0.12
48
197
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
260
1949
3.82
13.82
4.4
3.8
mmol/mol
35.6
37.4
4.20
252
1860
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
72
283
3.04
13.78
2.0
2.1
mmol/l
2.4
2.4
0.58
58
246
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
155
899
2.53
13.70
3.8
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
69
266
3.08
13.65
2.3
3.3
ng/l
883.3
383.0
0.37
51
214
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
17
9.89
13.56
1.5
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
107
526
2.62
13.34
2.2
1.8
mg/l
0.3
0.6
9.23
69
383
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
116
593
2.58
13.34
3.4
2.5
ng/l
33.7
16.0
0.35
32
227
(46235355) HIV 1 and 2 tests - Meaningful Use set
154
928
2.38
12.04
1.9
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
127
704
2.41
11.99
3.4
2.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
25
51
5.26
11.91
1.2
1.3
—
1.2
—
0
5
(3011048) Pyruvate [Moles/volume] in Blood
11
0
+∞
11.53
1.4
0.0
umol/l
82.4
—
—
11
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
16
9.14
11.20
1.2
1.0
u/l
0.9
1.0
—
6
9
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
286
2478
6.05
11.15
18.2
9.3
mg/l
14.9
18.5
1.45
232
1853
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
67
282
2.78
11.14
3.6
2.7
ng/l
49.4
238.5
1.74
18
145
(3019150) Specific gravity of Urine by Refractometry
99
507
2.43
10.99
3.5
2.8
kg/l
1.0
1.0
1.63
14
56
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
113
616
2.35
10.87
2.8
2.4
u/l
53.6
56.4
0.37
108
577
(3004588) Protein electrophoresis panel - Serum or Plasma
27
66
4.40
10.40
1.4
2.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
44
152
3.23
10.34
2.3
2.8
g/l
0.2
0.2
0.18
39
147
(40760892) CBC W Ordered Manual Differential panel - Blood
114
639
2.28
10.14
3.9
4.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
35
5.73
10.06
1.1
2.1
g/l
2.8
2.8
0.01
13
29
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
93
480
2.37
10.01
1.4
1.3
iu/ml
24.2
25.2
0.03
18
153
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
15
22
7.13
9.82
1.1
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
36
5.57
9.77
1.1
2.1
g/l
3.4
3.6
0.40
13
28
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
36
5.57
9.77
1.1
2.1
g/l
6.4
7.0
0.82
13
31
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
36
5.57
9.77
1.1
2.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
11
10.35
9.60
1.3
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
91
473
2.34
9.59
1.4
1.3
u/ml
1.3
11.2
1.92
37
201
(3018677) aPTT in Platelet poor plasma by Coagulation assay
55
225
2.78
9.57
2.1
2.8
s
29.6
30.0
0.28
55
220
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
6
22.57
9.43
1.1
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
479
2.30
9.27
3.2
2.9
—
—
—
0
0
(3013512) EKG study
80
399
2.38
9.22
3.6
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
267
2188
3.32
9.15
13.2
7.4
ml/min/173m2
96.8
95.8
0.41
237
1748
(3025941) Bacteria identified in Stool by Culture
41
147
3.08
9.03
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
221
2.70
8.86
1.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
263
2151
3.05
8.76
4.0
3.1
mmol/l
5.5
5.6
0.52
253
2028
(3022217) INR in Platelet poor plasma by Coagulation assay
36
123
3.19
8.58
4.4
10.8
inr
1.0
1.2
—
6
29
(36660697) Celiac disease serology panel - Serum
58
258
2.55
8.51
1.3
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
75
376
2.33
8.48
3.6
3.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
50
4.45
8.34
1.5
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
9
15.04
8.28
1.2
1.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
10
11
9.37
8.13
1.1
1.0
%
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
62
292
2.42
8.03
2.5
2.2
e6/l
0.6
0.9
0.67
33
163
(3015736) pH of Urine
137
886
2.02
7.97
2.9
2.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
44
176
2.76
7.94
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
81
3.57
7.87
1.1
1.1
u/ml
2.8
8.4
1.23
18
44
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
8
15.56
7.78
1.1
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
15
7.58
7.60
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
28
89
3.37
7.48
1.6
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
59
281
2.37
7.42
1.6
1.4
iu/l
22.2
22.0
0.01
50
243
(3025159) Blasts/100 leukocytes in Blood
38
146
2.84
7.38
5.3
3.7
%
0.0
0.1
—
5
30
(3002032) Base excess in Venous blood by calculation
33
118
3.02
7.28
3.9
5.7
mmol/l
2.2
1.8
0.27
27
91
(3032080) INR in Blood by Coagulation assay
94
547
2.05
7.18
4.4
4.4
inr
1.0
1.0
0.21
36
193
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
5
20.62
7.18
1.2
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
5
20.62
7.18
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
23
5.87
7.13
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
23
5.87
7.13
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
23
5.87
7.13
1.1
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
38
152
2.72
6.84
5.3
3.6
%
0.0
0.2
—
5
36
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
24
5.62
6.83
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
24
5.62
6.83
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
24
5.62
6.83
1.1
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
263
2225
2.68
6.80
18.7
11.4
%
13.0
13.4
7.34
257
2190
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
36
4.64
6.79
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
14
28
5.20
6.77
2.9
4.5
u/ml
155.5
86.3
—
5
9
(40761536) Microorganisms panel - Urine sediment
47
212
2.45
6.64
3.9
3.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
11
9
12.63
6.63
1.2
1.0
umol/l
20.7
20.7
—
11
9
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
70
3.48
6.56
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
25
5.39
6.55
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
39
162
2.62
6.52
1.9
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
34
132
2.78
6.47
1.4
1.3
u/l
8.6
11.1
0.56
28
107
(3030313) Adrenal Ab [Titer] in Serum
9
5
18.50
6.30
1.1
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
26
5.18
6.28
1.5
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
0
+∞
6.27
1.3
0.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
0
+∞
6.27
1.3
0.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
38
161
2.56
6.11
5.4
3.5
%
0.6
1.1
—
5
43
(3026008) Bacteria identified in Urine by Culture
96
592
1.92
6.07
3.7
2.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
13
27
4.99
6.03
1.2
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
50
243
2.27
5.96
1.9
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
145
2.60
5.88
2.5
1.9
mg/l
3.7
2.9
0.39
24
95
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
20
5.67
5.85
1.2
1.1
iu/ml
161.2
178.9
0.09
11
20
(3052851) Hemolysis interference index of Serum or Plasma
17
46
3.86
5.73
3.2
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
105
2.84
5.68
1.3
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
37
162
2.47
5.55
1.9
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
78
3.11
5.55
1.1
1.1
u/ml
1.0
0.6
0.19
13
36
(3000991) Gas panel - Venous blood
28
107
2.79
5.49
4.0
10.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
5
16.38
5.44
1.1
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
5
16.38
5.44
1.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
5
16.38
5.44
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
5
16.38
5.44
1.1
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
223
1823
1.91
5.41
3.4
2.8
u/l
30.3
33.0
0.38
216
1755
(3000492) Spirometry study
51
261
2.15
5.34
1.4
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
40
3.90
5.16
1.9
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
286
2643
3.69
5.14
14.9
8.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
35
156
2.41
5.06
6.9
7.5
mmol/l
104.0
104.5
0.29
35
150
(3022621) pH of Urine by Test strip
28
113
2.63
4.96
2.5
1.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
5
14.29
4.59
1.4
1.8
—
—
—
0
0
(4094501)
14
39
3.72
4.54
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
30
4.13
4.48
1.3
2.3
—
—
—
0
0
(4010399)
29
126
2.44
4.43
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
50
3.33
4.40
1.7
5.1
%
59.4
57.2
0.26
16
50
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
78
2.82
4.35
1.2
1.6
iu/ml
0.0
0.0
—
9
16
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
96
2.63
4.34
1.7
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
23
90
2.69
4.33
2.7
3.2
e9/l
57.1
77.9
3.33
18
69
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
9
9.10
4.30
1.6
1.7
umol/l
26.5
26.2
—
8
9
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
51
3.26
4.27
1.4
1.5
ug/g
405.6
353.4
—
9
30
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
41
3.53
4.24
1.1
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
40
204
2.11
4.22
2.7
2.4
u/l
29.1
33.1
0.37
35
170
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
32
3.87
4.13
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
114
816
1.65
4.04
2.0
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
38
3.53
3.95
1.0
1.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
10
24
4.28
3.92
1.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
49
3.17
3.86
1.5
4.7
e9/l
4.1
4.1
0.05
15
49
(3026493) Urate [Moles/volume] in Serum or Plasma
71
452
1.75
3.86
1.7
2.1
umol/l
294.0
2900.6
1.08
64
421
(3007853) Bacteria identified in Skin by Aerobe culture
42
227
1.99
3.80
2.0
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
125
927
1.60
3.78
2.1
1.9
—
—
—
0
0
(4306422)
15
50
3.11
3.74
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
79
526
1.69
3.64
1.5
1.6
mmol/l
1.4
1.4
0.05
67
470
(3012565) Volume of 24 hour Urine
7
9
7.93
3.57
1.6
2.0
ml
1994.3
1943.9
—
7
9
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
9
7.93
3.57
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
19
75
2.64
3.54
1.8
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
69
446
1.71
3.54
1.5
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
17
5.42
3.54
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
13
6.29
3.52
1.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
29
144
2.12
3.29
2.3
3.6
%
1.3
1.7
2.78
24
130
(1002224) Polysomnography panel
28
138
2.14
3.23
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
28
3.66
3.22
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
15
5.45
3.21
1.0
1.1
miu/ml
2810.7
1642.6
—
8
15
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
11
6.49
3.20
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
63
408
1.69
3.19
1.8
1.7
%
1.4
1.3
0.32
58
380
(3042936) Bacteria identified in Isolate by Culture
39
219
1.90
3.17
1.7
2.2
—
—
—
0
0
(3020891) Body temperature
14
50
2.89
3.13
4.4
6.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
93
2.35
3.11
1.4
2.2
iu/l
2.4
5.8
—
6
35
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
93
2.35
3.11
1.2
1.1
u/ml
0.2
2.3
—
10
39
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
22
100
2.30
3.08
1.8
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
51
2.83
3.03
1.2
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
5
10.14
2.99
1.2
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
5
10.14
2.99
2.0
2.8
ug/l
1.5
2.0
—
5
5
(3019060) Gas panel - Arterial blood
18
76
2.46
2.95
11.8
10.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
13
5.48
2.88
1.6
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
9
6.78
2.88
1.0
1.8
nmol/l
124.3
137.1
—
6
9
(3051611) Lipemic interference index of Serum or Plasma
6
9
6.78
2.88
2.3
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
14
53
2.72
2.83
5.7
3.6
%
50.0
52.8
0.15
14
53
(3028271) Lactate [Moles/volume] in Capillary blood
8
18
4.54
2.81
1.4
1.8
mmol/l
2.0
1.6
—
8
18
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
14
5.09
2.74
1.1
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
14
5.09
2.74
1.4
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
8
19
4.30
2.69
1.3
1.6
mmol/l
5.0
5.4
—
8
19
(3026389) Candida sp identified in Specimen by Organism specific culture
9
24
3.83
2.69
1.7
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
15
4.75
2.61
1.6
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
75
2.34
2.56
1.2
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
7
7.24
2.56
1.0
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
39
235
1.76
2.55
1.5
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
25
130
2.01
2.54
9.2
12.3
mmol/l
2.0
1.3
0.48
16
107
(3019225) pH of Specimen
27
145
1.95
2.51
2.7
3.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
26
3.54
2.50
1.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
16
4.45
2.49
1.1
1.6
—
—
—
0
0
(4035726)
25
132
1.98
2.44
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
52
345
1.62
2.39
1.6
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
42
264
1.69
2.37
2.2
2.1
u/l
872.4
2955.7
1.57
14
107
(42529406) Shigella sp [Presence] in Stool by Culture
17
78
2.25
2.36
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
65
2.38
2.35
1.6
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
28
3.28
2.32
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
99
2.09
2.32
1.2
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
96
735
1.45
2.28
2.2
2.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
13
4.69
2.28
2.5
3.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
19
93
2.11
2.27
2.3
3.5
mmol/l
1.9
0.8
0.54
14
65
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
18
3.96
2.26
1.1
1.0
u/ml
15.3
28.8
—
7
18
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
9
5.63
2.22
1.2
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
9
5.63
2.22
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
9
5.63
2.22
3.8
3.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
9
5.63
2.22
1.6
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
74
2.23
2.19
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
27
153
1.84
2.16
1.3
1.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
13
55
2.43
2.15
4.8
3.7
mmol/l
25.8
24.7
0.87
13
55
(3014133) Dog dander IgE Ab [Units/volume] in Serum
15
68
2.27
2.15
1.3
1.0
u/ml
0.3
3.2
—
5
20
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
251
2307
1.59
2.14
4.0
3.4
mmol/l
3.0
2.9
1.46
239
2193
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
87
663
1.44
2.10
2.1
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
170
1.78
2.09
1.2
1.2
—
—
—
0
0
(4024509)
5
10
5.06
2.08
1.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
10
5.06
2.08
4.6
11.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
76
2.17
2.06
2.4
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
40
258
1.64
2.06
2.0
2.6
umol/l
4.2
5.2
0.90
34
217
(3035320) C reactive protein [Mass/volume] in Body fluid
6
15
4.06
2.05
4.7
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
126
1.90
2.05
2.7
3.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
63
2.28
2.04
1.0
1.0
u/ml
4.0
1.8
—
5
33
(3034770) Mitochondria Ab [Titer] in Serum
16
77
2.14
2.00
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
91
707
1.42
1.96
1.8
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
263
0.47
1.95
1.2
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
11
4.60
1.95
1.0
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
6
16
3.80
1.94
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
16
3.80
1.94
1.2
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
191
1.70
1.90
5.4
4.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
22
3.23
1.89
1.1
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
40
2.55
1.85
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
40
2.55
1.85
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
40
2.55
1.85
1.6
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
17
3.58
1.84
1.7
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
26
154
1.75
1.83
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
68
507
1.44
1.83
2.3
2.9
mmol/l
9.0
8.6
0.27
59
454
(3021879) Hepatitis B virus core Ab [Presence] in Serum
41
275
1.57
1.81
1.6
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
54
2.27
1.76
1.2
1.2
u/ml
3.2
5.1
—
5
21
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
36
2.55
1.75
1.1
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
30
2.71
1.73
1.3
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
80
621
1.40
1.72
1.6
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
224
0.47
1.70
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
224
0.47
1.70
1.2
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
10
42
2.43
1.69
1.1
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
223
0.47
1.68
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
223
0.47
1.68
1.2
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
19
3.20
1.67
1.5
1.3
u/l
10.4
7.8
—
6
19
(3015076) Soybean IgE Ab [Units/volume] in Serum
7
25
2.84
1.66
1.0
1.0
—
0.2
—
0
5
(3023419) Bacteria identified in Sputum by Culture
5
14
3.61
1.62
1.8
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
59
439
1.43
1.60
1.6
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
26
2.73
1.59
3.4
8.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
26
2.73
1.59
1.4
2.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
138
1.72
1.57
2.5
2.1
ml/min/173m2
78.8
82.0
0.14
13
56
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
15
3.37
1.53
1.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
27
2.63
1.52
1.1
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
246
2294
1.44
1.51
3.9
3.3
mmol/l
4.9
4.8
0.54
235
2186
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
205
1.57
1.48
2.0
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
83
667
1.34
1.42
2.0
2.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
67
1.98
1.40
1.6
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
9
41
2.23
1.38
1.1
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
145
1.64
1.33
3.6
2.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
31
442
0.67
1.33
1.5
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
244
2287
1.39
1.32
3.8
3.2
mmol/l
1.5
1.5
0.73
232
2177
(3022313) Gas panel - Capillary blood
13
69
1.92
1.30
2.5
3.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
34
2.39
1.30
1.3
2.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
238
0.57
1.26
1.2
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
25
2.43
1.25
1.3
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
25
2.43
1.25
1.2
1.1
—
4.8
—
0
7
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
6
25
2.43
1.25
1.2
1.8
—
706.2
—
0
11
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
186
0.52
1.22
1.2
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
26
2.33
1.19
1.5
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
26
2.33
1.19
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
151
1.57
1.15
1.5
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
182
0.53
1.14
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
181
0.54
1.13
1.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
32
2.22
1.09
1.0
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
52
1.96
1.07
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
52
1.96
1.07
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
33
2.15
1.06
1.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
22
2.29
1.04
1.8
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
22
2.29
1.04
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
92
1.66
0.99
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
394
0.71
0.98
1.3
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
30
0.00
0.98
0.0
2.0
—
263.6
—
0
16
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
27
2.25
0.94
1.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
27
2.25
0.94
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
63
1.77
0.91
2.2
1.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
23
161
1.46
0.89
2.2
1.9
u/ml
24.5
36.2
0.46
23
154
(40768443) Skin Pathology biopsy report
13
79
1.68
0.89
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
60
492
1.28
0.89
1.7
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
56
1.81
0.89
6.1
20.3
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
31
1.95
0.85
1.5
1.1
nmol/l
28.9
36.2
—
6
22
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
47
1.72
0.81
1.9
2.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
257
2471
1.31
0.81
16.5
10.2
%
40.9
40.4
0.54
221
2109
(3021901) Oxygen saturation in Capillary blood
5
25
2.02
0.73
1.0
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
39
1.81
0.73
1.3
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
204
1.36
0.72
1.1
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
42
1.68
0.69
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
86
762
1.18
0.62
1.6
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
230
2204
1.20
0.61
3.6
3.0
mmol/l
1.3
1.2
0.26
219
2096
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
175
1.34
0.60
1.2
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
32
256
1.28
0.60
2.3
1.7
—
—
—
0
0
(4268621)
6
39
1.55
0.53
2.3
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
45
382
1.21
0.52
3.2
4.2
mg/mmol
31.7
11.5
0.39
29
256
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
189
1.29
0.51
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
119
1.36
0.49
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
218
1.26
0.48
1.1
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
27
218
1.26
0.48
1.1
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
27
219
1.26
0.47
1.1
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
118
1092
1.13
0.46
3.9
3.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
27
220
1.25
0.45
1.1
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
51
1.38
0.44
1.3
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
56
496
1.16
0.41
1.9
1.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
35
1.44
0.39
2.2
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
239
2324
1.15
0.39
19.5
11.9
g/l
335.3
333.3
3.30
239
2310
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
68
1.33
0.38
2.1
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
157
0.75
0.37
1.4
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
91
1.33
0.34
1.3
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
32
276
1.18
0.33
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
184
0.81
0.29
1.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
41
366
1.14
0.29
2.7
3.4
mg/l
3250.2
446.3
0.68
24
244
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
63
1.28
0.28
1.9
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
347
0.88
0.23
1.9
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
5
39
1.29
0.23
2.8
2.1
g/l
140.2
131.9
—
5
28
(3032868) Hemoglobin electrophoresis panel in Blood
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
11
0.00
0.21
0.0
36.1
—
6.7
—
0
11
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.21
0.0
5.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
10
0.00
0.21
0.0
10.7
—
37.8
—
0
5
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
8.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
16
136
1.19
0.20
1.2
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
194
1.14
0.19
1.3
1.4
—
—
—
0
0
(4034850)
7
61
1.15
0.17
18.6
5.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
80
0.74
0.15
2.3
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
78
1.16
0.15
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
78
1.16
0.15
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
230
2270
1.06
0.13
5.0
3.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
142
1.13
0.13
2.4
2.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
48
1.04
0.09
1.6
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
65
1.08
0.08
1.4
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
137
1.10
0.07
2.4
2.7
%
23.8
22.1
—
6
35
(3003694) ABO and Rh group [Type] in Blood
85
865
0.98
0.04
1.6
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
40
388
1.04
0.04
1.6
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
251
1.04
0.02
1.7
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
155
0.97
0.00
1.4
1.7
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
7.1
—
0
7
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
103
1030
1.00
0.00
2.1
2.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
6.1
—
0
5
(3045788) Cell count panel - Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_POSTVIRFAT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have G6_POSTVIRFAT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: G6_POSTVIRFAT – Postviral fatigue syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data